Origin Biosciences
www.origintx.comOrigin Biosciences, a subsidiary of BridgeBio Pharma, is a biotechnology company focused treatment for Molybdenum Cofactor Deficiency (MoCD). Origin is led by a team of veteran biotechnology executives. Together with patients and physicians, the company aims to bring a safe, effective treatment for MoCD to market as quickly as possible.
Read more
Origin Biosciences, a subsidiary of BridgeBio Pharma, is a biotechnology company focused treatment for Molybdenum Cofactor Deficiency (MoCD). Origin is led by a team of veteran biotechnology executives. Together with patients and physicians, the company aims to bring a safe, effective treatment for MoCD to market as quickly as possible.
Read more
Country
State
California
City (Headquarters)
Palo Alto
Industry
Employees
11-50
Founded
2018
Estimated Revenue
$1 to $1,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Senior Vice President of Technical Operations
Email ****** @****.comPhone (***) ****-****Vice President , Business Development and Operations
Email ****** @****.comPhone (***) ****-****Associate Director , Regulatory Affairs Cmc
Email ****** @****.comPhone (***) ****-****Head of Regulatory , Vice President , Regulatory Affairs
Email ****** @****.comPhone (***) ****-****
Reach decision makers at Origin Biosciences
Free credits every month!
Origin Biosciences FAQ
Palo Alto, United States
Biotechnology Research
